G4032 Rheumatology MIPS — Reimbursement & Policy | OpenPayer

Summary & Overview

HCPCS G4032: Rheumatology MIPS Specialty Set

HCPCS Level II code G4032 identifies the Rheumatology MIPS specialty set, a collection of quality measures used to assess performance for rheumatology clinicians participating in the Merit-based Incentive Payment System. Nationally, MIPS reporting influences payment adjustments and public quality transparency, making specialty-specific measure sets like this central to value-based policy and practice for rheumatology providers. Key payers considered in national discussions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will find an overview of what G4032 represents, why specialty-specific MIPS measure sets matter for practice-level reporting and reimbursement, and how the code fits into broader quality measurement and compliance workflows. The publication covers benchmarks and reporting context, recent policy updates affecting MIPS measure sets, typical clinical and administrative uses for rheumatology practices, and practical considerations for integrating the specialty set into electronic health record and billing workflows. Data not available in the input will be noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG4032HCPCS Level IIrheumatologyMIPSquality measuresperformance reportingambulatory carevalue-based care

Billing Code Overview

HCPCS Level II code G4032 denotes the Rheumatology MIPS specialty set. This code represents a predefined group of quality measures and performance metrics used within the Merit-based Incentive Payment System (MIPS) framework specifically for clinicians practicing in rheumatology.

Service type: Quality reporting and performance measurement for rheumatology clinicians
Typical site of service: Outpatient rheumatology clinics and ambulatory care settings

Clinical & Coding Specifications

Clinical Context

A 58-year-old patient with established rheumatoid arthritis presents for a scheduled quality reporting visit with their rheumatologist as part of the Rheumatology MIPS specialty set. The visit occurs in an outpatient rheumatology clinic and includes a focused history and medication review, assessment of disease activity (joint counts and patient-reported outcomes), documentation of functional status and safety monitoring for disease-modifying antirheumatic drugs (DMARDs), and reconciliation of laboratory monitoring results. The clinical workflow typically includes intake by nursing staff (vital signs, patient questionnaires), clinician assessment (joint exam, medication adjustment if indicated), ordering or review of relevant labs (CBC, CMP, hepatic panel), and submission of required data elements into the MIPS reporting system or certified EHR. Typical encounter documentation supports quality measure reporting and may be billed with an evaluation and management or procedure CPT code as appropriate; G4032 identifies the encounter as part of the Rheumatology MIPS specialty set for reporting purposes.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when work required to provide the service is substantially greater than typically required.

HCPCS G8725: Fasting Lipid Profile (Triglycerides, LDL-C, HDL-C, Total Cholesterol)

HCPCS-G9499-HEPATITIS-C-NO-ANTIVIRAL-TREATMENT-DOCUMENTATION

HCPCS G9499: Hepatitis C, No Antiviral Treatment Documented

HCPCS-G2152-NECK-IMPAIRMENT-RESIDUAL-SCORE

HCPCS G2152: Residual Neck Impairment Score Calculated

HCPCS-G8735-ELDER-MALTREATMENT-SCREEN-POSITIVE-NO-FOLLOW-UP

HCPCS G8735: Elder Maltreatment Screen Positive, No Follow-Up

HCPCS-G9721-WHEELCHAIR-BOUND-NON-AMBULATORY-STATUS

HCPCS G9721: Non-ambulatory / Wheelchair-Bound Functional Status

HCPCS-G9489-REMOTE-IN-HOME-EVALUATION-MANAGEMENT-ESTABLISHED-PATIENT

HCPCS G9489: Remote In-Home Evaluation and Management, High Complexity

HCPCS-G2058-CHRONIC-CARE-MANAGEMENT-ADDITIONAL-20-MIN

HCPCS G2058: Chronic Care Management, Additional 20 Minutes

HCPCS-G1001-CLINICAL-DECISION-SUPPORT-EVICORE-APPROPRIATE-USE

HCPCS G1001: Clinical Decision Support Mechanism (evicore)

HCPCS-G0271-MEDICAL-NUTRITION-THERAPY-GROUP-REASSESSMENT

HCPCS G0271: Medical Nutrition Therapy Group Reassessment

HCPCS-G8721-PATHOLOGY-PT-PN-HISTOLOGIC-GRADE-DOCUMENTATION

HCPCS G8721: Pathology Documentation of PT, PN, and Histologic Grade

Showing 1–10 of 1996

Taxonomy Code	Specialty	Notes
`207RP0000X`	Rheumatology	Primary specialty performing MIPS rheumatology reporting and clinical care.
`207L00000X`	Internal Medicine	Commonly provides longitudinal care for inflammatory arthritis patients.
`207RH0002X`	Allergy & Immunology	May co-manage autoimmune inflammatory conditions and immunomodulatory therapy.
`208000000X`	Family Medicine	Provides primary care coordination and chronic disease management for rheumatology patients.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`M05.79`	Rheumatoid arthritis with rheumatoid factor of multiple sites without organ or system involvement	Common rheumatoid arthritis diagnosis reported in rheumatology quality sets.
`M06.9`	Rheumatoid arthritis, unspecified	Used when RA diagnosis is documented but specific details are not available; relevant to MIPS rheumatology reporting.
`M06.0`	Seropositive rheumatoid arthritis	Specific RA code often present in patients requiring DMARD management and quality monitoring.
`M13.9`	Arthropathy, unspecified	Used for inflammatory joint disease when specific etiology is unclear; may appear in general rheumatology panels.
`M45.9`	Ankylosing spondylitis, unspecified	Representative spondyloarthritis diagnosis included in rheumatology practice patient populations.
`M32.9`	Systemic lupus erythematosus, unspecified	Common systemic autoimmune diagnosis managed within rheumatology and relevant to specialty reporting.
`M35.9`	Systemic involvement of connective tissue, unspecified	Broad connective tissue disease code that may be used when specific diagnosis is not coded but patient is managed by rheumatology.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, low to moderate severity	Common visit-level code used for routine rheumatology follow-up visits during which MIPS data elements are collected.
`99214`	Office or other outpatient visit for the evaluation and management of an established patient, moderate to high severity	Used when the rheumatology visit requires moderate to high medical decision making or more extensive care coordination and documentation for MIPS reporting.
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Used when intra-clinic medication administration (e.g., biologic injection performed in office) occurs during the visit associated with MIPS reporting.
`96413`	Chemotherapy administration, intravenous infusion technique, up to 1 hour, single or initial substance/drug	Applicable when intravenous infusions (e.g., certain biologic therapies administered in infusion centers) are part of the rheumatology treatment workflow related to quality reporting.
`81002`	Urinalysis, non-automated, without microscopy	Common point-of-care or lab test ordered and reviewed as part of safety monitoring documented for MIPS measures.
`85025`	Complete blood count (CBC) with automated differential	Routine laboratory monitoring for DMARDs and biologics; results are reviewed and documented during the visit for safety measure reporting.

OpenPayer